Clinical Trials · NCT01321723
Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Unigene Laboratories Inc.
- Enrollment
- 97
- Start date
- Feb 2011
- Locations
- 4 sites, Denmark, Estonia
- Primary endpoint
- % Change From Baseline BMD in L1-L4 Axial Lumbar Spine at Week 24